New York & Tri-State CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Regeneron Buys Avon R&D Facility in Suffern
Regeneron Pharmaceuticals has acquired Avon Innovation Center, a 235,000-square-foot research and development property in Suffern, NY, from Avon. The sale price was not disclosed.
Cushman & Wakefield represented the seller with a team of Larry Carroll, Shawn Straka, David Bernhaut, Frank DiTommaso, and Seth Zuidema, alongside Michael Katz of Actio Corporate Advisors. The buyer, Regeneron Pharmaceuticals, was represented by Dan Loughlin and Matt Loughlin of JLL.
“We are pleased with the successful sale of Avon’s iconic Suffern facility,” said Bernhaut. “This acquisition signifies a major user transaction in the market, with promising economic growth opportunities for the surrounding region. It was a pleasure to team with Actio Corporate Advisors and support Avon’s global real estate team through this process.”
There’s still time to register for the Connect Industrial Midwest 2024 event on March 5 at Joe’s Live in Rosemont, Illinois. Click here for more information and to sign up.
- ◦Sale/Acquisition
